- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Improving RSV Vaccination Rates and Addressing Misinformation
Experts on RSV provide insights on improving RSV vaccination rates, highlighting ways to navigate misinformation.
Video Player is loading.
EP: 1.Overview of RSV Patient Populations
EP: 2.Complications Associated with RSV Infections
EP: 3.The Economic Burden and Main Drivers of Healthcare Resource Utilization in RSV
EP: 4.RSV: Risk Factors and How It’s Spread
EP: 5.Diagnostic Practices for RSV
EP: 6.Increasing Awareness of RSV Vaccines in At-Risk Patients
EP: 7.Shared Decision-Making Practices in RSV
EP: 8.Financial and Clinical Benefits of RSV Immunization
EP: 9.The Potential Benefits of RSV Vaccine Approval for Adults Aged 50-59
EP: 10.Addressing Vaccine Fatigue
EP: 11.Identifying Patients Eligible for RSV Vaccine
EP: 12.Current and Potential Obstacles Related to Administering RSV Vaccines
EP: 13.Improving Insurance Coverage for RSV Vaccines
Now Viewing
EP: 14.Improving RSV Vaccination Rates and Addressing Misinformation
EP: 15.Key Takeaways on RSV Vaccination
Video content above is prompted by the following questions:
- How do you avoid any missed chances to vaccinate against RSV?
- How do you address misinformation out there about RSV with patients?
Related Videos
Evolution of Oncology Pharmacy Practice in mCRC
The Patient Journey: Mapping the Pharmacist’s Role in mCRC Management
Optimizing Treatment Sequencing in Advanced Colorectal Cancer
Quality of Life and Patient Outcomes in mCRC Treatment
Comparing Safety Profiles: Making Informed Treatment Decisions in mCRC
Treatment Options in mCRC: A Clinical Overview
Closing Thoughts on Iron Deficiency Anemia
The Future of IV Iron Administration
Final Takeaways From the Panelists
Future Treatment of Patients With Alopecia Areata
Related Content
